Damian Hiley

As the Director of Business Development at Desert King International, I lead the development, launch, and commercialization of Quillaja Saponin based vaccine adjuvants for veterinary and human pre-clinical, clinical and commercial applications. With over 12 years of experience in this role, I have successfully navigated the complex regulatory landscape and established strategic partnerships with key stakeholders in the biotech industry. My background in biology and economics, combined with my MBA from the Paul Merage School of Business at UC Irvine, has equipped me with a unique blend of scientific and business acumen. I have a proven track record of driving growth and innovation in the biotech sector, with a focus on vaccine adjuvants. My expertise spans from product development to sales and marketing, and I am passionate about advancing the field of biotechnology and improving public health outcomes.